Aethlon Medical, Inc. - AEMD

SEC FilingsOur AEMD Tweets

About Gravity Analytica

Recent News

  • 06.09.2025 - Aethlon Medical to Present New Pre-Clinical Data at the Keystone Symposium on Long COVID and Other Post-Acute Infection Syndromes
  • 06.09.2025 - Aethlon Medical to Present New Pre-Clinical Data at the Keystone Symposium on Long COVID and Other Post-Acute Infection Syndromes
  • 05.14.2025 - Aethlon Medical Announces Publication of Preclinical Data Showing Ability of the Hemopurifier® to Remove Platelet-Derived Extracellular Vesicles from Plasma
  • 05.14.2025 - Aethlon Medical Announces Publication of Preclinical Data Showing Ability of the Hemopurifier® to Remove Platelet-Derived Extracellular Vesicles from Plasma
  • 02.13.2025 - Aethlon Medical to Present at the Emerging Growth Conference on February 19, 2025
  • 02.13.2025 - Aethlon Medical to Present at the Emerging Growth Conference on February 19, 2025

Recent Filings

  • 06.05.2025 - 8-K Current report
  • 05.15.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
  • 05.13.2025 - 8-K Current report
  • 04.25.2025 - 4 Statement of changes in beneficial ownership of securities
  • 04.25.2025 - 4 Statement of changes in beneficial ownership of securities
  • 04.25.2025 - 4 Statement of changes in beneficial ownership of securities
  • 04.25.2025 - 4 Statement of changes in beneficial ownership of securities
  • 04.18.2025 - DEF 14A Other definitive proxy statements
  • 04.08.2025 - PRE 14A Other preliminary proxy statements
  • 04.01.2025 - 4 Statement of changes in beneficial ownership of securities